Janux Therapeutics, Inc. ($JANX)
Filing Information
| Accession Number | 0002032671-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 3, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
62,997
Total Value
$20,073.26
P&L
+inf% (+$864,455.99)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vice President, Accounting | Common Stock | โ | Jan 2, 2026 | Sale | 1,462 | $13.73 | $20,073.26 | 15,373 | Direct | โ | View Details | |
Vice President, Accounting | Common Stock | โ | Jan 2, 2026 | Grant/Award | 18,935 | $0.00 | $0.00 | 34,308 | Direct | โ | View Details | |
Vice President, Accounting | Stock option (right to buy) | Derivative | Jan 2, 2026 | Grant/Award | 42,600 | $0.00 | $0.00 | 42,600 | Direct | โ | View Details |